BankPlus Wealth Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
BankPlus Wealth Management's DGX Position: Q3 2026 in Review
BankPlus Wealth Management increased its Quest Diagnostics (DGX) stake by 0.19% in Q3 2026, buying an estimated $1.16K and bringing the position to 2,579 shares worth $601K. The position accounts for 0.26% of the portfolio, ranked #60.
BankPlus Wealth Management first reported a position in DGX in Q4 2024 and has held it in 8 quarters since. 1,142 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- BankPlus Wealth Management held 2,579 shares of Quest Diagnostics worth $601K as of Q3 2026.
- BankPlus Wealth Management bought 5 Quest Diagnostics shares in Q3 2026, an estimated $1.16K.
- Quest Diagnostics made up 0.26% of BankPlus Wealth Management's portfolio in Q3 2026, its #60 holding.
- BankPlus Wealth Management first reported a position in Quest Diagnostics in Q4 2024 and has held it in 8 quarters since.
- 1,142 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on BankPlus Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.